1. ARNOLD, C.; LAM-HIMPLIN, M.D.; MONTGOMERY E.A. Atlas of Gastrointestinal Pathology: A Pattern Based Approach to Non-Neoplastic Biopsies- 2014 – Lippincott Williams & Wilkins.
  2. Barnhill RL, Crowson NA, Magro CM and Perpkorn MW. Dermatopathology. Third Edition. The McGraw-Hill Companies, Inc. 2010.
  3. Becker JC, Stang A, DeCaprio JA, Cerroni L, Lebbé C, Veness M and Nghiem P. Merkel cell carcinoma. Nat Rev Dis Primers.2017 Oct 26;3:17077. doi: 10.1038/nrdp.2017.77.
  4. Busam KJ, Walsh N and Wood BA. Merkel cell carcinoma in Elder DE, Massi D, Scolyer RA and Willemze R, editors. WHO classification of skin tumors. 4th 2018.
  5. Calonje E, Brenn T, Lazar A and McKee PH. McKee’s Pathology of the skin with clinical correlations. Fourth Edition. Saunders – Elsevier Inc. St. Louis, Missouri – USA,
  6. Chen, L; Berek, JS. Overview of epithelial carcinoma of the ovary, fallopian tube, and peritoneum. Aug 06, 2019. www.uptodate.com
  7. Chen, VW; Ruiz, B; Killeen, JL; Coté, TR; Wu, XC; Correa, CN; et al. Pathology and classification of ovarian tumors. Cancer. 2003;97:2631–42.
  8. Choueiri TK, Cheville J, Palescandolo E, Fay AP, Kantoff PW, Atkins MB, McKenney JK, Brown V, Lampron ME, Zhou M, Hirsch MS, Signoretti S. BRAF mutations in metanephric adenoma of the kidney. Eur Urol. 2012 Nov;62(5):917-22. doi: 10.1016/j.eururo.2012.05.051. Epub 2012 Jun 9. PubMed PMID: 22727996; PubMed Central PMCID: PMC4516083
  9. Chui MH, Xing D, Zeppernick F, Wang ZQ, Hannibal CG, Frederiksen K, Kjaer SK, Cope L, Kurman RJ, Shih IM, Wang TL, Vang R. Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma. Am J Surg Pathol. 2019 Nov;43(11):1462-1472.
  10. FITZGIBBONS, P. L. Histochemistry in the diagnosis of non-neoplastic gastrointestinal disorders. Semin Diagn Pathol, v. 35, n. 6, p. 370-380, Nov 2018.
  11. Folkins, AK et al.A Candidate Precursor to Pelvic Serous Cancer (p53 Signature) and Its Prevalence in Ovaries and Fallopian Tubes from Women with Heterozygous BRCA Mutations. Gynecol Oncol. 2008 May; 109(2): 168–173.
  12. GOLDBLUM, J. R. et al. Rosai and Ackerman’s Surgical Pathology. Elsevier Health Sciences, 2017.
  13. Goldblum, John R., et al. Rosai and Ackerman’s Surgical Pathology. Elsevier Health Sciences, 2017.
  14. Graeser, M et al. A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res. 2010. Dec 15;16(24):6159-68.
  15. Grignon DJ, Al-Ahmadie H, Algaba F, Amin MB, Comperat E, Dyrskjt L, Epstein JI, Hansel DE, Knuchel R, Lloreta J, Lope z-Beltran A, McKenney JK, Netto GJ, Paner G, Reuter VE, Shen SS, Van der Kwast T. Tumours of the urinary tract. In: Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed. Lyon, France: IARC; 2016.
  16. Hatano,Y; Hatano, K; Tamada, M; Morishige, KI; Tomita, H; Yanai, H; Hara, A. A Comprehensive Review of Ovarian Serous Carcinoma. Adv Anat Pathol. 2019 Sep;26(5):329-339.
  17. Hoda SA, Rosen PP. Rosen’s breast pathology. Fourth edition / Syed A. Hoda, Edi Brogi, Fred Koerner and Paul Peter Rosen. Ed 2015.
  18. Jonathan I. Epstein, George J. Netto. Differential diagnoses in surgical pathology: genitourinary system. Philadelphia, PA: Lippincott Williams & Wilkins; 2014.
  19. Kinney SN, Eble JN, Hes O, Williamson SR, Grignon DJ, Wang M, et al. Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma. Mod Pathol. 2015 Sep;28(9):1236-48. doi: 10.1038/modpathol.2015.81. Epub 2015 Aug 7. PubMed PMID: 26248896
  20. KUMAR, V.; ABBAS, A.; ASTER, J. C. Robbins & Cotran Patologia-bases patológicas das doenças. Elsevier Brasil, 2015.
  21. Kurman, RJ; Carcangiu, ML; Herrington, CS; et al. WHO Classification of Tumours of the Female Reproductive Organs. Lyon: WHO Press; 2014.
  22. Lam-Himlin DM, Montgomery EA, Arnold CA. Atlas of Gastrointestinal Pathology. A pattern Based Approach to Neoplastic Biopsies. Workers Kluwer, Philadelphia, 2019.
  23. Le Page, C; Chung, J; Rahimi, K; Kobel, M; Provencher, D; Mes-Masson, AM. Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas. Curr Drug Targets. 2019 Oct 16.
  24. Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD, Crum CP. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007:21126–35.
  25. Leroux-Kozal V, Lévêque N, Brodard V, Lesage C, Dudez O, Makeieff M, Kanagaratnam L and Diebold MD. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load. Human Pathology (2015) 46, 443-453. **site da SBP – http://www.sbp.org.br/associados/revistas.html.
  26. Kleppe, A.C. Kraima, R.F. Kruitwagen, et al., Understanding lymphatic drainage pathways of the ovaries to predict sites for sentinel nodes in ovarian cancer, Int. J. Gynecol. Cancer 25 (8) (2015 Oct) 1405–1414.
  27. Malpica, A; Deavers, MT; Lu, K; et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004; 28:496–504.
  28. Mantoan Padilha M, Billis A, Allende D, Zhou M, Magi-Galluzzi C. Metanephric adenoma and solid variant of papillary renal cell carcinoma: common and distinctive features. Histopathology. 2013 May;62(6):941-53. doi: 10.1111/his.12106. Epub 2013 Apr 3. PubMed PMID: 23551615.
  29. Manual de Laudos Histopatológicos. Online, 5ª. edição 2019. http://www.sbp.org.br/manual-laudos-histopatologicos/.
  30. Mettler TN, Manivel JC, Pambuccian SE. “Raspberry bodies,” extracellular hyaline globules and branching hyaline stromal fragments in a fine-needle aspirate of metastatic clear cell carcinoma of the ovary. Diagn Cytopathol. 2014 Mar;42(3):230-5.
  31. NOFFSINGER, A. E. Fenoglio-Preiser’s gastrointestinal pathology. Lippincott Williams & Wilkins, 2017.
  32. Olgac S, Hutchinson B, Tickoo SK, Reuter VE. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma. Mod Pathol. 2006 Feb;19(2):218-24. PubMed PMID: 16424894.
  33. PAI, R. K. A practical approach to small bowel biopsy interpretation: celiac disease and its mimics. Semin Diagn Pathol, v. 31, n. 2, p. 124-36, Mar 2014.
  34. Ping Tang, MD, PhD; Gary M. Tse M. Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma A 2015 Update Arch Pathol Lab Med. 2015;140.
  35. Pinto A, Signoretti S, Hirsch MS, Barletta JA. Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma. Histopathology. 2015 May;66(6):901-4. doi: 10.1111/his.12509. Epub 2015 Jan 23. PubMed PMID:25130952
  36. Plaza JA and Suster S. The Toker tumor Spectrum of morphologic features in primary neuroendocrine carcinomas of the skin (Merkel cell carcinoma). Annals of Diagnostic Pathology 10 (2006) 376 – 385. **site da SBP – http://www.sbp.org.br/associados/revistas.html
  37. Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast. 2018 College of American Pathologists (CAP).
  38. Protocol for the Examination of Specimens From Patients With Merkel Cell Carcinoma of the Skin. Version MerkelCell 4.0.0.1. June 2017 College of American Pathologists (CAP).
  39. RATNAIKE, R. N. Whipple’s disease. Postgrad Med J, v. 76, n. 902, p. 760-6, Dec 2000.
  40. Reid, MR; Permuth, JB; Sellers, TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017 Feb; 14(1): 9–32.
  41. Rendi, MH. Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Histopathology. Jun 06, 2019.www.uptodate.com
  42. Ritterhouse LL, Barletta JA. BRAF V600E mutation-specific antibody: A review. Semin Diagn Pathol. 2015 Sep;32(5):400-8. doi: 10.1053/j.semdp.2015.02.010. Epub 2015 Feb 7. Review. PubMed PMID: 25744437
  43. Rosen PP, Brogi E, Ferry JA, Hoda SA, Koerner FC. Breast pathology: diagnosis by needle core biopsy. 3rd ed. Wolters Kluwer. 2017.
  44. Sampaio SAP e Rivitti EA. Dermatologia. Editora Artes Médicas Ltda – São Paulo – SP. 3ª. edição, 2007.
  45. Sarpel, U. (2014) Lymphadenectomy. In: Surgery, pp. 245-255. Springer, New York, NY
  46. Singer, G; Oldt R III; Cohen Y; et al. Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst. 2003;95:484–486.
  47. Tickoo SK, Reuter VE. Differential diagnosis of renal tumors with papillary architecture. Adv Anat Pathol. 2011 Mar;18(2):120-32. doi: 10.1097/PAP.0b013e31820cb3dd. Review. Erratum in: Adv Anat Pathol. 2015 Jul;22(4):281. PubMed PMID: 21326010.
  48. Udager AM, Pan J, Magers MJ, Palapattu GS, Morgan TM, Montgomery JS, et al. Molecular and immunohistochemical characterization reveals novel BRAF mutations in metanephric adenoma. Am J Surg Pathol. 2015 Apr;39(4):549-57. doi: 10.1097/PAS.0000000000000377. PubMed PMID: 25602792; PubMed Central PMCID: PMC4359621.
  49. Vang, R; Levine, DA; Soslow, RA; et al. Molecular alterations of TP53 are a defining feature of ovarian high-grade serous carcinoma: a rereview of cases lacking TP53 mutations in the Cancer Genome Atlas Ovarian Study. Int J Gynecol Pathol. 2016;35:48–55.
  50. Vang, R; Shih, IE; Kurman, RJ. Ovarian Low-Grade and High-Grade Serous Carcinoma: Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems. Adv Anat Pathol. 2009 Sep; 16(5): 267–282.
  51. Weedon D. Weedon‘s Skin Pathology. Churchill Livingstone/Elsevier, Third edition, 2010.
  52. WHO Classification of Tumours: Digestive System Tumours, 5th ed. Lyon, 2019.
  53. Wick Mark R. and Leslie Kevin O.”. Practical Pulmonary Pathology, A Diagnostic Appproach. Elsevier, 2011: 241-252.
  54. Wick Mark R. and Leslie Kevin O.”. Practical Pulmonary Pathology, A Diagnostic Appproach. Elsevier, 2011: 252-257.
  55. Wick Mark R. and Leslie Kevin O.”. Practical Pulmonary Pathology, A Diagnostic Appproach. Elsevier, 2011: 244-245.
  56. Wiermann EG”. Manual de Condutas. Sociedade brasileira de Oncologia Clínica. Ed. O Lutador, outubro de 2011, p. 34. ISSN 1806-6054. Manual do PACQ SBP segunda edição, rol de procedimentos.
  57. Zhou M, Netto GJ, Epstein JI. Uropathology: high-yield pathology. Philadelphia, PA: Elseviers Saunders; 2012.
Referências de edições anteriores